The Influence of Manual and Verbal Guidance for Therapeutic Results in People With Parkinson's Disease

February 14, 2019 updated by: University of Sao Paulo General Hospital

Effects Of Physiotherapy Intervention In A Motor Training With Virtual Reality On Motor, Cognitive, Balance And Gait Of Patients With Parkinson Disease: A Randomized Clinical Trial

A prospective, single-blind, parallel-group, randomised trial was conducted in Sao Paulo, Brazil. Thrid eight People with Parkinson's Disease were recruited and randomly allocated in two groups: Experimental Group (EG), that performed the balance and gait training based on games from Microsoft Xbox Kinect System ® (MXKS) supported by manual and verbal guidance (MVG) provided by a PT and a control group (CG) that performed an identical training with no MVG during the training.

Study Overview

Detailed Description

It were recruited PPD in the "Brazil Parkinson Association" (BPA), a no-government association of PD care, where the assessments and intervention were performed from December 2017 to June 2018. The PPD were recruited by randomization from the BPA list of active patients and waiting list for PT intervention.

Outcome measures were obtained at up to three time points: before intervention, after 1 week and after 8 weeks of the end of intervention, the last time point was considered as a follow-up assessment. This study is in agreement with CONSORT guidelines for developing randomised trials . Primary measures was the functional balance evaluation by the Balance Evaluation Systems Test (BESTest) and Rapid Turn Test (RT Test), and gait performance assessed in the six-minute walk test and Gait test in 30 seconds. As secondary measures were used: Unified Parkinson's Disease Rate Scale (UPDRS), 5-Step Standing Passing Test (ST-DP5), International Falls Efficiency Scale (FES-I), Brazilian Version of the Freezing Scale March (FOGQ), Parkinson's Disease Quality of Life Questionnaire (PDQ-39), Geriatric Depression Scale (GDS-15).

All patients performed 8 individual training sessions, under the supervision of a physiotherapist, twice a week for four weeks. Each session had 10 minutes of identical global exercises for both groups, consisting of stretching, muscle strengthening and axial mobility exercises, one serie per session. After these initial 10 minutes, both groups performed an additional 40 minutes of balance training using four XBOX games, four per session, under different conditions for MVG and NMVG.

While the Control Group will be trained by conventional Physical Therapy exercises.

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • São Paulo, Brazil, 04142-092
        • Brazil Parkinson Association
      • São Paulo, Brazil, 05360-160
        • Department of Physiotherapy, Communication Science & Disorders, Occupational Therapy, School of Medicine, University of São Paulo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Parkinson's disease diagnosis according to Parkinson's Disease Society Brain Bank of London criteria
  • Active treatment with levodopa
  • Classification in stages 1, 2 and 3 according to Hoehn and Yahr Classification

Exclusion Criteria:

  • Severe cognitive impairment defined as ≤ 20 in Montreal Cognitive Assessment
  • Severe respiratory and / or cardiovascular conditions
  • Visual and / or auditory deficit that can not be corrected with orthotics;
  • Other previously detected orthopedic or neurological diseases, other than Parkinson's Disease, that may interfere with the individual's performance;
  • Previous experience with Microsoft XBOX Kinect® games;
  • Be in rehab at another location concomitant with study training.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Manual and verbal guidance (MVG)
The MVG Group will be done by experimental group with the manual and verbal guidance of a physiotherapist using four games of X-Box Kinect system®
Participants will perform 4 balance games during 8 sessions with a manually and verbally assisted by a experient physiotherapist.
Other Names:
  • Experimental Group with Manual and Verbal Guidance (MVG)
Participants will perform 4 balance games during 8 sessions in the presence of a experient physiotherapist that will ensure patient safety, providing motivational verbal stimuli, and replicating the feedback provided by the game.
Other Names:
  • Experimental Group with No Manual and Verbal Guidance (NMVG)
Patients of the control group will be trained with balance exercises by a experient physiotherapist.
Other Names:
  • Control Group
Experimental: No manual and verbal guidance (NMVG)
The NMVG Group will be done by experimental group using four games of X-Box Kinect system® in the presence of a physiotherapist that will care about the safety of the participants without interfere in their moviment pattern.
Participants will perform 4 balance games during 8 sessions with a manually and verbally assisted by a experient physiotherapist.
Other Names:
  • Experimental Group with Manual and Verbal Guidance (MVG)
Participants will perform 4 balance games during 8 sessions in the presence of a experient physiotherapist that will ensure patient safety, providing motivational verbal stimuli, and replicating the feedback provided by the game.
Other Names:
  • Experimental Group with No Manual and Verbal Guidance (NMVG)
Patients of the control group will be trained with balance exercises by a experient physiotherapist.
Other Names:
  • Control Group
Active Comparator: Physical Therapy
The Control Group will be trained by conventional Physical Therapy exercises.
Participants will perform 4 balance games during 8 sessions with a manually and verbally assisted by a experient physiotherapist.
Other Names:
  • Experimental Group with Manual and Verbal Guidance (MVG)
Participants will perform 4 balance games during 8 sessions in the presence of a experient physiotherapist that will ensure patient safety, providing motivational verbal stimuli, and replicating the feedback provided by the game.
Other Names:
  • Experimental Group with No Manual and Verbal Guidance (NMVG)
Patients of the control group will be trained with balance exercises by a experient physiotherapist.
Other Names:
  • Control Group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Functional balance and gait with Best Test
Time Frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)
A scale consisting of 36 items, the score having a variation in four levels, 0 being the worst performance and 3 the best, with a total score of 108. This scale evaluates the balance under six different domains: biomechanical changes, stability / verticality limits, anticipatory postural adjustments, postural responses, sensory orientation and gait stability
1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)
Change in Gait with 6 minut walk test
Time Frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)
a gait assessment method that measures the maximum distance a person can walk and measures maximal cardiorespiratory functions
1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)
Change in Functional balance with Rapid turn test
Time Frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)
Is a mesure of dynamic balance. The subject tested turns in a complete circle (360 degrees) as faster as it could while time to finshed the turn is recorded. The test is done for both sides (right and left).
1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Specific motor and non-motor aspects of Parkinson's disease with UPDRS scale
Time Frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)
It's a scale composed of four parts: Part I (non-motor aspects of daily life), Part II (motor aspects of daily life), Part III (motor evaluation) and Part IV (motor complications)
1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)
Risk of falls with FES-I scale
Time Frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)
presents questions about the concern with the possibility of falling when performing 16 activities, with respective scores from one to four. The total score can range from 16 (no concern) to 64 (extreme worry)
1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)
Endurance with 6 minut walk test
Time Frame: 1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)
a gait assessment method that measures the maximum distance a person can walk and measures maximal cardiorespiratory functions
1 week before beginning the training; after 1 week of the end of training; and after 8 weeks of the ending the training (follow up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Elisa P Piemonte, University of Sao Paulo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2017

Primary Completion (Actual)

April 30, 2018

Study Completion (Anticipated)

July 20, 2019

Study Registration Dates

First Submitted

September 5, 2018

First Submitted That Met QC Criteria

December 11, 2018

First Posted (Actual)

December 12, 2018

Study Record Updates

Last Update Posted (Actual)

February 18, 2019

Last Update Submitted That Met QC Criteria

February 14, 2019

Last Verified

July 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe